(Q24297029)

Erb-b2 receptor tyrosine kinase 2

GOA release 2020-03-11

1 reference

ErbB-3 class receptor binding

GOA release 2020-03-11

1 reference

Journal of Biological Chemistry

GOA release 2020-03-11

author name string

Elicia Penuel

series ordinal

1

0 references

Robert W Akita

series ordinal

2

0 references

Mark X Sliwkowski

series ordinal

3

0 references

language of work or name

English

0 references

publication date

9 August 2002

0 references

published in

0 references

volume

277

0 references

issue

32

0 references

page(s)

28468-73

0 references

cites work

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Identification of a heregulin binding site in HER3 extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Mammalian cell transient expression of tissue factor for the production of antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

DNA Sequence Analysis of the Type-Common Glycoprotein-D Genes of Herpes Simplex Virus Types 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

HER2/neu: mechanisms of dimerization/oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

The single transmembrane domains of ErbB receptors self-associate in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Extracellular domains drive homo- but not hetero-dimerization of erbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Neu receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Binding specificities and affinities of egf domains for ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Domain-specific Interactions between the p185neuand Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200

Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202510200